Results 161 to 170 of about 7,552 (172)
Some of the next articles are maybe not open access.
Overview of Mechanisms of Drug-Induced Liver Injury (DILI) and Key Challenges in DILI Research
2018Nabil Noureddin, Neil Kaplowitz
openaire +1 more source
Genetic Basis of Anti-Tuberculosis Drug-Induced Liver Injury (AT-DILI)
Anti-tuberculosis drug-induced liver injury (AT-DILI) is a severe adverse drug reaction associated with using anti-tuberculosis medications. Isoniazid, rifampicin, and pyrazinamide are potentially hepatotoxic drugs used in TB treatment. The rate of AT-DILI ranges from 2 to 28%, and this is also attributed to genetic factors.Heikrujam Nilkanta Meitei +3 more
openaire +1 more source
A Case Report of Rifampin Alone Drug Induced Liver Injury (DILI)
American Journal of Gastroenterology, 2018Ashina D. Singh +2 more
openaire +1 more source
Doxycycline: Rare but Real Cause of DILI (Drug-Induced Liver Injury)
International Journal of Pharmaceutical Research, 2020openaire +1 more source
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Gastroenterology, 2015, Robert FONTANA, Paul Watkins
exaly
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury
International Journal of Molecular Sciences, 2016Maria Isabel Lucena Gonzalez +2 more
exaly

